Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeOverexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune responseRediscovering ACE: novel insights into the many roles of the angiotensin-converting enzymeUse of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionAn endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.Hepatitis delta virus: the molecular basis of laboratory diagnosis.Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigenThe carboxypeptidase ACE shapes the MHC class I peptide repertoireMice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma.Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c miceMucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.Toward computational determination of peptide-receptor structure.H-2Dd exploits a four residue peptide binding motif.Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTLSupraoptimal peptide-major histocompatibility complex causes a decrease in bc1-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytesDeletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis.Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequenceTargeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion proteinSerum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.Analysis of the association of peptides of optimal length to class I molecules on the surface of cellsDynorphin peptides differentially regulate the human kappa opioid receptorProteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.A dominant negative mutant beta 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain.Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors.A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein.Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment.Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining.The angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian patients with vitiligo: a case-control study and meta-analysis.Binding of alanine-substituted peptides to the MHC class I protein, Kd.Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases.Production of murine leukemia RLmale1 rejection antigen peptide pRL1a by proteolysis of natural precursor pRL1b.
P2860
Q24306614-2BC12229-0A3C-4C15-A2DC-7D96E9BF03E2Q26750677-8AD54F50-7951-4961-BC3A-BBF2A94790CEQ27004277-A9108897-86D1-4ED1-9624-D66CD35E7607Q27480326-A33DE2FE-05A8-48BA-BAB4-155B86843B7AQ31019004-F2D8AF0E-C908-44D5-A622-799B2E5F79B9Q33784928-DA5E175E-5BFE-4076-B2F8-437974C2B3BDQ33875709-CE85996A-1583-48C7-94A1-615191927FDBQ34659770-1D6ED989-E358-4D49-A8A0-3676586DF88BQ35402189-7C740D6B-8525-4D76-87C4-8D94ECB266EFQ35855609-5D26574C-0E75-4131-B9EA-34E9427EC9A0Q35860387-8F0E2577-C6B3-429E-9226-3A08C130A12FQ35884740-8A700635-A5C5-47F2-BD60-092660A5D09EQ36277738-7414CC55-F5A5-41B4-9FA5-DF584B71221AQ36362613-5E2229C0-0993-4620-A31B-092A52247F52Q36363927-60E078D2-5B7A-4AD2-B832-8C5BAE5BCBB3Q36365348-AB2EA108-27A4-45ED-BDB1-C2547B911B12Q36365487-26404801-8C29-43C8-8CBD-56A98A283259Q36365966-8F3C2B75-07B4-40FF-8165-526D1D8B424EQ36367150-F847ADE3-69CD-40B6-A688-E68EE48D079CQ36404247-9C011566-DF0B-4282-A1A0-FB68CA7C3954Q36497672-FAC8B855-B330-4AD3-B489-2F9BD006D657Q36597984-6DAAB378-9FA4-494C-AF2F-40CE6841FA10Q36635448-E1D969FF-FF14-4CA8-A4B5-FAC9790A9849Q37190471-FFB24086-BC11-4FF9-90A0-2083F660A417Q37214311-584A741C-DD97-4A62-B1C8-02A0B76EE317Q37227827-7A5C04C0-E921-4791-B743-4C96DD125672Q37424484-7983A034-2EEE-4369-8A76-7DAA7E2C9C27Q38360461-1BCE5FE9-3EAA-4E9E-BCDA-2B5284CABDD4Q39646814-0CCCB562-C540-4954-A66E-0253BB395941Q40331084-DC19058F-FACA-4E4F-B4EF-430EC8FBA731Q40851948-0377C9E9-8029-4775-9871-370B91594BE8Q40963061-B9A6D739-1672-4161-9288-CDB0CC495E3FQ41845687-4522C517-5EFD-450F-A245-BDAC94F32AF5Q44619554-AD05EB9C-D214-4B0E-8B74-C1594293268BQ45808797-429CB911-5F27-42D7-B03B-C793A17A9793Q52545701-32797116-1ABA-4732-9663-364BE071A86FQ54158424-6EE4A148-0D62-4CFD-B951-8E0F6FC06921Q55204931-54A58D88-9552-40B1-A7A3-E82700D4AF43
P2860
Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Serum angiotensin-1 converting ...... lity complex class I molecules
@ast
Serum angiotensin-1 converting ...... lity complex class I molecules
@en
Serum angiotensin-1 converting ...... lity complex class I molecules
@nl
type
label
Serum angiotensin-1 converting ...... lity complex class I molecules
@ast
Serum angiotensin-1 converting ...... lity complex class I molecules
@en
Serum angiotensin-1 converting ...... lity complex class I molecules
@nl
prefLabel
Serum angiotensin-1 converting ...... lity complex class I molecules
@ast
Serum angiotensin-1 converting ...... lity complex class I molecules
@en
Serum angiotensin-1 converting ...... lity complex class I molecules
@nl
P2093
P2860
P3181
P356
P1476
Serum angiotensin-1 converting ...... lity complex class I molecules
@en
P2093
C D Pendleton
D H Margulies
J A Berzofsky
R N Germain
S Kozlowski
T Takeshita
P2860
P304
P3181
P356
10.1084/JEM.175.6.1417
P407
P577
1992-06-01T00:00:00Z